Arcadia Biosciences Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
9
- Stock Symbol
-
RKDA
- Investments
-
10
- Share Price
-
$4.88
- (As of Thursday Closing)
Arcadia Biosciences General Information
Description
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
Contact Information
Website
www.arcadiabio.comCorporate Office
- 5950 Sherry Lane
- Suite 215
- Dallas, TX 75225
- United States
Corporate Office
- 5950 Sherry Lane
- Suite 215
- Dallas, TX 75225
- United States
Arcadia Biosciences Timeline
Arcadia Biosciences Stock Performance
As of 12-Jun-2025, Arcadia Biosciences’s stock price is $4.88. Its current market cap is $6.67M with 1.37M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.88 | $5.00 | $2.40 - $10.31 | $6.67M | 1.37M | 11.9K | -$1.49 |
Arcadia Biosciences Financials Summary
As of 31-Mar-2025, Arcadia Biosciences has a trailing 12-month revenue of $5.26M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | (27) | 1,712 | (11,092) | (13,835) |
| Revenue | 5,259 | 5,045 | 4,454 | 7,418 |
| EBITDA | (1,631) | (4,978) | (5,729) | (10,624) |
| Net Income | (2,016) | (7,038) | (13,981) | (15,376) |
| Total Assets | 12,990 | 13,517 | 19,705 | 28,922 |
| Total Debt | 21 | 155 | 1,007 | 2,017 |
Arcadia Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Arcadia Biosciences Comparisons
Industry
Financing
Details
Arcadia Biosciences Competitors (10)
One of Arcadia Biosciences’s 10 competitors is Keygene, a Corporate Backed or Acquired company based in Wageningen, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Keygene | Corporate Backed or Acquired | Wageningen, Netherlands | ||||
| Manus | Venture Capital-Backed | Waltham, MA | ||||
| Cibus | Formerly VC-backed | San Diego, CA | ||||
| Fera Science | Private Equity-Backed | York, United Kingdom | ||||
| Yield10 Bioscience | Formerly VC-backed | Woburn, MA |
Arcadia Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Arcadia Biosciences Patents
Arcadia Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021336542-A1 | Methods of increasing fiber in a wheat grain | Pending | 07-Sep-2020 | ||
| CA-3191219-A1 | Methods of increasing fiber in a wheat grain | Pending | 07-Sep-2020 | ||
| EP-4211250-A1 | Methods of increasing fiber in a wheat grain | Inactive | 07-Sep-2020 | ||
| US-20230413751-A1 | Methods of increasing fiber in a wheat grain | Inactive | 07-Sep-2020 | ||
| US-20200291415-A1 | Soybeans with reduced antinutritional factor content | Active | 15-Mar-2019 | A01H1/06 |
Arcadia Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Arcadia Biosciences Investments & Acquisitions (10)
Arcadia Biosciences’s most recent deal was a Seed Round with Fauna Bio for . The deal was made on 21-Sep-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fauna Bio | 21-Sep-2021 | Seed Round | Drug Discovery | ||
| Lief Holdings | 17-May-2021 | Merger/Acquisition | Personal Products | ||
| Saavy Naturals | 17-May-2021 | Merger/Acquisition | Personal Products | ||
| Zola (Beverages) | 17-May-2021 | Merger/Acquisition | Beverages | ||
| Agrasys | 19-Apr-2021 | Merger/Acquisition | Cultivation |
Arcadia Biosciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Food Products
Industry
Rank
Percentile
Agriculture
Subindustry
Rank
Percentile
Arcadia Biosciences Exits (2)
Arcadia Biosciences’s most recent exit was on 17-May-2021 from Saavy Naturals. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Saavy Naturals | 17-May-2021 | Completed |
|
||
| Verdeca | 28-Feb-2012 | Joint Venture | Completed |
|
Arcadia Biosciences Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Agrasys | Barcelona, Spain | 2006 | |
| Zola (Beverages) | Dallas, TX | 2001 |
Arcadia Biosciences FAQs
-
When was Arcadia Biosciences founded?
Arcadia Biosciences was founded in 2002.
-
Where is Arcadia Biosciences headquartered?
Arcadia Biosciences is headquartered in Dallas, TX.
-
What is the size of Arcadia Biosciences?
Arcadia Biosciences has 9 total employees.
-
What industry is Arcadia Biosciences in?
Arcadia Biosciences’s primary industry is Cultivation.
-
Is Arcadia Biosciences a private or public company?
Arcadia Biosciences is a Public company.
-
What is Arcadia Biosciences’s stock symbol?
The ticker symbol for Arcadia Biosciences is RKDA.
-
What is the current stock price of Arcadia Biosciences?
As of 12-Jun-2025 the stock price of Arcadia Biosciences is $4.88.
-
What is the current market cap of Arcadia Biosciences?
The current market capitalization of Arcadia Biosciences is $6.67M.
-
What is Arcadia Biosciences’s current revenue?
The trailing twelve month revenue for Arcadia Biosciences is $5.26M.
-
Who are Arcadia Biosciences’s competitors?
Keygene, Manus, Cibus, Fera Science, and Yield10 Bioscience are some of the 10 competitors of Arcadia Biosciences.
-
What is Arcadia Biosciences’s annual earnings per share (EPS)?
Arcadia Biosciences’s EPS for 12 months was -$1.49.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
